The therapeutical effect of OX26/CTX-PL/pC27 complex and western blot analysis. (A) The cell viability of the C6 glioma cells after transfection of OX26/CTX-PL/pC27 complex at a series of plasmid weights. (B) The viability of C6 glioma cells after transfection of OX26/CTX-PL/pEGFP, PL/pC27, OX26-PL/pC27 and OX26/CTX-PL/pC27 at 0.2 μg pDNA. (C) Western blot analysis of the expression of hTERTC27 in C6 glioma cells after transfections of OX26/CTX-PL/pEGFP, PL/pC27, OX26-PL/pC27 and OX26/CTX- PL/pC27complexes at 4 μg pDNA. OX26/CTX-PL/pEGFP was set as the negative control.